Dr. Lal PathLabs introduces advanced test for amyloidosis to detect protein accumulation: Our Bureau, Bengaluru Tuesday, April 15, 2025, 14:15 Hrs [IST] Dr Lal PathLabs Limited ha ...

"We believe that experimentally creating amyloid fibrils, which mimic the fibrils in various subtypes of Alzheimer's disease, will reveal the complex mechanisms of Alzheimer's," says Ishii.

Medical testing laboratory Dr. Lal PathLabs said on Tuesday that it has become south Asia’s first diagnostic chain to offer an advance test for amyloidosis, a rare but critical disease caused by ...

From these regions, the scientists identified two main subtypes of microglia that were only found in ... to see exactly where these and other cells sat in relation to amyloid deposits. Immediately ...

N-acetylcysteine (NAC) shows promise to treat hereditary cystatin C amyloid angiopathy (HCCAA) HCCAA – a subtype of cerebral amyloid angiopathy (CAA) – is an ultra-rare Icelandic amyloid ...

Gantenerumab helps eliminate one of the neurological hallmarks of Alzheimer’s, called amyloid plaques. For some participants, gantenerumab reduced their risk of developing the disease by more ...

This gold standard advanced test, powered by Laser Microdissection & Mass Spectrometry allows us to precisely identify amyloid subtypes, helping clinicians provide targeted care. With this launch ...